×
Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial PDF
$ 40.00
Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial PDF quantity
$ 40.00
×
Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors: Results From a Placebo-Controlled, Randomized, Double-Blind, Placebo Wash-In Study PDF
$ 40.00
Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors: Results From a Placebo-Controlled, Randomized, Double-Blind, Placebo Wash-In Study PDF quantity
$ 40.00
×
Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-d-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder PDF
$ 40.00
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-d-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
